Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier. - Wikidata - wikimedia - TriplyDB

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.

http://www.wikidata.org/entity/Q38351240

about

In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents.Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.Imaging transporters: Transforming diagnostic and therapeutic development.Evaluation of [18F]MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood-brain barrier in rats: Kinetics, metabolism, and selectivity.Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood-Brain Barrier.Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice.Blood-brain barrier: an impediment to neuropharmaceuticals.Vascular Toxicity Risk Assessment of MC18 and MC70, Novel Potential Diagnostic Tools for In Vivo PET Studies.

P2860

Q38761314-420CEA97-A88C-46F8-9D66-138DF7964744 Q38844653-7B34FEAB-4DA2-402A-8FC0-6CD6F3B71C58 Q38871905-D4A33630-23CC-4F74-8169-9AF534F3E681 Q39647414-7D865ED6-8B48-4201-B7AC-6C67DD109EA7 Q41690663-C655F211-7264-4874-8F25-146187CF7EDF Q42366889-B9A98300-9FD1-4684-AD41-307A259FA999 Q47845084-8394FB46-50BA-458E-A457-3429E38C9176 Q48334832-D31A1FF5-1336-4AA3-BF68-8D8C354A7BF8 Q51302992-ADC283E4-C6A3-4F15-B3B1-E89A8010920B

P2860

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.

http://www.wikidata.org/entity/Q38351240

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.

@en

type

label

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.

@en

prefLabel

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.

@en

P1433

Q38351240-8DD1A089-9E85-4688-976A-653EF013461F

P1476

Q38351240-2C639B0A-A3B0-4D84-828B-3F824BF29D58

P2093

Q38351240-230B8358-73EC-46A2-B555-3F7E046389E7

Q38351240-299B1609-A415-475D-9955-A7F55747B922

Q38351240-7FE2B71F-AAB1-4B49-BBE9-18DC190396D9

Q38351240-A9E68D2F-0D8F-4F23-B66F-A4D705969C7F

P2860

Q38351240-0604E09F-51AC-418E-B18C-DD140BA9334B

Q38351240-0F735694-8DAF-4532-AB6C-DCEC3596D5C1

Q38351240-0FED8866-E409-452B-AC2E-CD1C8E53AD5F

Q38351240-11F20EC5-5F16-4F91-9ECB-9B572FF41B89

Q38351240-1FF59666-EB63-4EBB-9CFE-F93B2DD26A6C

Q38351240-25F86B9E-807A-444E-9B24-4FF3DAA5A441

Q38351240-26DAE716-8988-4E7A-8941-FA4CA4835878

Q38351240-2CBFC519-8EFF-4E42-B5F0-CB4B06062B55

Q38351240-2D04495D-2C7B-46C7-9BFE-8129DD67EC8F

Q38351240-3076D5B5-C3EB-4BD0-9366-03128EF3E42F

P304

Q38351240-B01169BE-0366-4760-8ABF-B4D5FDDF011F

P31

Q38351240-E347AF01-7945-411C-BFD6-A61DB5138CEF

P356

Q38351240-10865BC7-4F90-4072-9483-AB5E586D0507

P407

Q38351240-C6861277-AE07-407B-9853-4A0158AC18F6

P433

Q38351240-0E414419-0810-421A-8AEE-0981DD3BB13B

P478

Q38351240-00D033A1-3097-410B-883D-9173A39333FF

P50

Q38351240-B6137476-852D-4AAF-81DB-9C77041C173C

Q38351240-F3A1EEBB-83BD-486B-8C31-9898423103BF

P577

Q38351240-6EBF79D9-1139-43DD-B339-44C68DC5B84F

P5875

Q38351240-89307B4A-285E-4720-81CE-FAB90CDDC1CF

P698

Q38351240-BDC75389-28C7-4A11-A10C-87790ED8D72E

P921

Q38351240-26561A47-7FB1-4B2A-AEB8-C51790AA143D

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier

@en

P2093

G Luurtsema

http://www.w3.org/2001/XMLSchema#string

N A Colabufo

http://www.w3.org/2001/XMLSchema#string

P H Elsinga

http://www.w3.org/2001/XMLSchema#string

R M Raaphorst

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

Staging of brain pathology related to sporadic Parkinson's disease

The blood-brain barrier in health and chronic neurodegenerative disorders

The blood-brain barrier: an overview: structure, regulation, and clinical implications

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

beta-Amyloid efflux mediated by p-glycoprotein.

P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide.

Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.

P304

362-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.73

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Albert D. Windhorst

Adriaan A Lammertsma

P577

2015-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270967791

http://www.w3.org/2001/XMLSchema#string

P698

25669763

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier